Compass Therapeutics, Inc. Share Price
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
15:16:25 22/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.8120 USD | -0.31% |
|
-6.28% | -84.35% |
| 09-23 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| 09-23 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
| Market Cap | 147M 131M 121M 110M 206M 13.84B 209M 1.45B 569M 7.28B 550M 539M 23.18B | P/E 2026 * |
-1.64x | P/E 2027 * | -1.46x |
|---|---|---|---|---|---|
| Enterprise Value | -3.32M -2.96M -2.74M -2.48M -4.67M -313M -4.72M -32.82M -12.88M -165M -12.45M -12.19M -525M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 2.1x |
| Free-Float |
87.53% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CMPX | Delayed | |
CBOE
| CMPX | Real-time |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | -0.06% | ||
| 1 week | -6.28% | ||
| Current month | -19.19% | ||
| 1 month | -32.23% | ||
| 3 months | -58.80% | ||
| 6 months | -84.20% | ||
| Current year | -84.35% |
| 1 week | 0.81 |  | 0.91 |
| 1 month | 0.81 | | 1.23 |
| Current year | 0.81 | | 6.88 |
| 1 year | 0.81 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 27/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 08/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 31/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 31/12/2013 |
Phil Ferneau
BRD | Director/Board Member | 64 | 31/12/2014 |
Carl Gordon
CHM | Chairman | 61 | 31/12/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Buy | Controller/Auditor | 20,000 | 0.0111% | ||
| 24/09/26 | Buy | Controller/Auditor | 2,500 | 0.0014% | ||
| 29/04/26 | Buy | Controller/Auditor | 15,000 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.31% | -6.28% | -79.80% | -54.57% | 147M | |
| -0.21% | -4.43% | +44.40% | +74.13% | 66.22B | |
| +1.35% | +5.19% | +12.52% | +76.98% | 55.2B | |
| +1.30% | +4.50% | +12.68% | +92.61% | 52.79B | |
| +0.43% | +2.82% | +27.91% | +51.69% | 45.53B | |
| -1.53% | +2.22% | +21.96% | +126.62% | 43.94B | |
| -2.31% | +2.30% | +265.46% | +954.86% | 41.64B | |
| +0.10% | +9.90% | +16.11% | +59.33% | 34B | |
| -8.38% | -6.95% | +26.35% | -1.93% | 25.84B | |
| +1.07% | +5.14% | +38.49% | +28.27% | 23.51B | |
| Average | -0.78% | +2.93% | +38.61% | +140.80% | 38.88B | |
| Weighted average by Cap. | -0.48% | +3.72% | +50.70% | +165.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.51M 5.8M 5.37M 4.86M 9.16M 615M 9.27M 64.41M 25.27M 323M 24.43M 23.92M 1.03B |
| Net income | -93.27M -83.11M -76.95M -69.63M -131M -8.8B -133M -923M -362M -4.63B -350M -343M -14.74B | -112M -99.55M -92.16M -83.4M -157M -10.54B -159M -1.11B -434M -5.54B -419M -410M -17.66B |
| Net Debt | -150M -134M -124M -112M -211M -14.15B -213M -1.48B -582M -7.44B -563M -551M -23.71B | -133M -119M -110M -99.3M -187M -12.55B -189M -1.32B -516M -6.6B -499M -489M -21.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/10/26 | US$0.8404 | +3.18% | 68,653 |
| 21/10/26 | US$0.8145 | -2.26% | 1,544,138 |
| 20/10/26 | US$0.8333 | -0.20% | 1,883,132 |
| 19/10/26 | US$0.8350 | -2.91% | 3,119,040 |
| 16/10/26 | US$0.8600 | -4.09% | 2,038,934 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
